International efforts are underway. The Global Action Plan on Antimicrobial Resistance, endorsed by WHO member states, calls for better surveillance, prudent use of antibiotics, and investment in new drugs. However, the pipeline for novel antibiotics remains dangerously thin. Since 1987, only a few new classes of antibiotics have been discovered, as pharmaceutical companies find them less profitable than chronic disease medications.
Patients seeking help in hospitals can inadvertently contaminate other patients. International efforts are underway